Dr. MacVicar adds to Illinois CancerCare's expertise in cancers, specifically, genitourinary malignancies, including prostate, kidney, bladder and testicular cancers.
Peoria, IL (PRWEB) September 12, 2013
Dr. Paul Fishkin, President, Illinois CancerCare, P.C., is proud to announce the addition of Gary R. MacVicar, M.D. to their staff of committed professionals. Dr. MacVicar adds to Illinois CancerCare's expertise in cancers, specifically, genitourinary malignancies, including prostate, kidney, bladder and testicular cancers.
Dr. MacVicar is a graduate of the University of Chicago Pritzker School of Medicine and completed his clinical training at the University of Michigan Health System with a Residency in Internal Medicine and a Fellowship in Hematology and Medical Oncology.
Prior to joining Illinois CancerCare, Dr. MacVicar served on staff at the Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital in Chicago. Although he treats patients with a variety of genitourinary malignancies, including testicular and kidney cancers, he has a particular interest in bladder and prostate cancers. He has been involved in phase II trials of bladder and prostate cancers, several of which involve novel targeted therapies. He has been an active member of the Eastern Cooperative Oncology Group (ECOG) Genitourinary Committee, and he has served on the National Comprehensive Cancer Network (NCCN) Prostate Cancer Guidelines Committee as well as the American Society of Clinical Oncology (ASCO) Genitourinary Education Committee. He has presented at both the ASCO Annual Meeting and the ASCO Genitourinary Cancers Symposium.
About Illinois CancerCare:
Illinois CancerCare is one of the largest practices in the state of Illinois that treats patients with cancer and blood diseases. It provides state of the art treatments to its patients against these complex diseases by staying at the leading edge of clinical research. Illinois CancerCare is central Illinois’ largest network of cancer care specialists with 90-120 open clinical cancer research trials being conducted at any given time. The group has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program for outpatient hematology-oncology practices that meet the highest national standards for quality cancer care. Illinois CancerCare’s Community Clinical Oncology Program (CCOP) is one of the nation’s top enrollers in clinical trials, ranking 9tt in cancer clinical trials in the newly formed Alliance of Clinical Trials in Oncology. Illinois CancerCare has 17 physicians, 16 APN’s and more than 230 staff members. Illinois CancerCare serves patients in 13 cities and 12 counties throughout central and western Illinois including Bloomington/Normal, Canton, Carthage, Eureka, Galesburg, Kewanee, Macomb, Monmouth, Ottawa, Pekin, Peoria, Peru and Princeton. For further information, please visit http://www.illinoiscancercare.com.